Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
Mark Thomas Smith
How do we choose the right bioprocessing technologies for the short and long term?
Lori Muffly believes collaboration and innovation – bolstered during the COVID-19 pandemic – will guide the future of stem cell transplant.
If the industry can figure out 3D printing’s regulatory hurdles, we may be on the cusp of a revolution: the democratization of personalized precision.
We speak with G-CON’s Maik Jornitz about his career and desire to give back by training the next generation.
Watch our video interview with Maik Jornitz.
Mighty mRNA molecules have won the COVID-19 vaccine race, but there is room for improvement.
To speed up vaccine development, we need to assess our bioconjugation approaches.
How do we vaccinate billions of people? “Nobody wins the race until everyone wins.”
Billions of vaccine doses equate to a need for billions of primary packaging units – and glass vials are still top dog.
Experts from Colorcon explain how the company’s investments in facilities and new technologies are helping the pharma sector reach its goals.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
X2: Researchers United
Autoinjectors: Through Thick and Thin
Staying on the Track to Eradication